Trial Sponsors Seek New Countries As Russian Market ‘Falls Into The Abyss’

The Russian clinical trials organization ACTO says the “gloomy” prospects for multinational clinical trials in the country have led many sponsors to postpone the initiation of new studies or abandon them entirely in favor of other markets.